Sequent Scientific Limited (BOM:512529)
India · Delayed Price · Currency is INR 189.40
-4.60 (-2.37%)
At close: Sep 26, 2025
Sequent Scientific Company Description
Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally.
The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals.
It also offers analytical services; and VET formulation services. The company was formerly known as PI Drugs & Pharmaceuticals Ltd. and changed its name to Sequent Scientific Limited in October 2009.
The company was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments.
Sequent Scientific Limited
| Country | India |
| Founded | 1985 |
| Industry | Pharmaceutical Preparations |
| Employees | 1,244 |
| CEO | Rajaram Narayanan |
Contact Details
Address: Dosti Pinnacle Mumbai, 400604 India | |
| Phone | 91 22 4111 4777 |
| Website | sequent.in |
Stock Details
| Ticker Symbol | 512529 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Rajaram Narayanan | Chief Executive Officer |
| Saurav Bhala | Chief Financial Officer |
| Abhishek Singhal | Head of Investor Relations |